Fortress Biotech, Inc. - Significant Ownership

Signature - Title
Fortress Biotech, Inc. - Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer
Location
Bay Harbor Islands, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Fortress Biotech, Inc..

Significant Ownership of Fortress Biotech, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MBIO Mustang Bio, Inc. Common Stock, $0.0001 Par Value 12.4% $1.71M 6.57M Fortress Biotech, Inc. Dec 31, 2024
CKPT Checkpoint Therapeutics, Inc. Common Stock, $0.0001 Par Value 11.2% $27.6M 6.92M Fortress Biotech, Inc. Mar 9, 2025
ATXI Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value 10.3% $253K 329K Fortress Biotech, Inc. Mar 31, 2025
MBIO Mustang Bio, Inc. Common Stock, $0.0001 Par Value 7.9% $279K 199K Fortress Biotech, Inc. Mar 31, 2025

Schedules 13D/G Reported by Fortress Biotech, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.